CHRONIC MYELOID LEUKEMIA - Biological Basis of Therapy
Organizers:
J.M. Goldman (UK)
J. Cortes (USA)
T.P. Hughes (Australia)
Co-Organizers:
P. Hari, T. Holyoake, F.-X. Mahon, D. Perrotti, J. Radich

Despite the impressive clinical results of tyrosine kinase inhibitors in the management of patients with CML, many unresolved questions remain. This meeting brings together scientists with new data on the cellular, molecular and immune biology of CML, some of which may eventually translate into new therapeutic approaches that would enable the clinician to discontinue therapy with the expectation that the leukaemia would not recur.

WORLD CORD BLOOD CONGRESS (CORD BLOOD 2)
President: E. Gluckman
Scientific Committee: W. Arcese, H.E. Broxmeyer, J. Kurtzberg, F. Locatelli, A. Madrigal, V. Rocha, G. Sanz,
E.J. Shpall, J. Wagner, S. Takahashi
Local Organiser: C. Chabannon

The upcoming WORLD CORD BLOOD CONGRESS will cover a wide range of topics including cord blood transplant in adults and children, the role of HLA in cord blood transplant, stem cells, cord blood banking and regulatory issues. A international panel of distinguished scientists and clinicians will participate in this major international forum over three days of interactive conferencing. The scientific programme will comprise a series of plenary presentations and debates. Poster sessions and short oral communications selected from submitted abstracts will enable registered participants to present their own data.

The WORLD CORD BLOOD CONGRESS is open to all the professional actors working in the fields related to cord blood biology and clinical applications, from both the public and private sectors, including physicians, research scientists, technicians, data analysts and nurses. The congress will also be of interest to healthcare policy decision makers.

DIAGNOSTIC WORK-UP
FOCUS ON ACUTE MALIGNANCIES
Chairs: B. Bain, W. Erber, R. Foà, G. Zini

The aim of Tutorial courses is to offer a un update on technological advances for early diagnosis, preserving a strong link to traditional morphology and histopathology, as well as providing information on new therapeutic strategies.
Courses are organized  using three different didactic tools, which are formal lectures, tutored clinical cases and interactive self-evaluation test-cases sessions. Type 1 Tutorials use original material, while Type 2 and Type 3 utilize educational material that has already been presented, updated as necessary.
This Tutorial is a Type 1, which means a new one with lectures and educational material specially prepared; it is focused on Acute Malignancies.
The program will cover the diagnostic pathway from morphology, through flow cytometry and genetics/molecular genetics to clinical and therapeutic  aspects of both Myeloid and Lymphoid Acute Malignancies.